|
|
||||||||
INFLAMMATION/IMMUNITY/MEDIATORS
1Department of Pharmacology and 2Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada
Submitted 22 December 2004 ; accepted in final form 29 April 2005
Central nervous system (CNS) infection and inflammation severely reduce the capacity of cytochrome P-450 metabolism in the liver. We developed a mouse model to examine the effects of CNS inflammation on hepatic cytochrome P-450 metabolism. FVB, C57BL/6, and C3H/HeouJ mice were given Escherichia coli LPS (2.5 µg) by intracerebroventricular (ICV) injection. The CNS inflammatory response was confirmed by the elevation of TNF-
and/or IL-1
proteins in the brain. In all mouse strains, LPS produced a 6070% loss in hepatic Cyp3a11 expression and activity compared with saline-injected controls. Adrenalectomy did not prevent the loss in Cyp3a11 expression or activity, thereby precluding the involvement of the hypothalamic-adrenal-pituitary axis. Endotoxin was detectable (110 ng/ml) in serum between 15 and 120 min after ICV dosing of 2.5 µg LPS. Peripheral administration of 2.5 µg LPS by intraperitoneal injection produced similar serum endotoxin levels and a similar loss (60%) in Cyp3a11 expression and activity in the liver. The loss of Cyp3a11 in response to centrally or peripherally administered LPS could not be evoked in Toll-like receptor-4 (TLR4)-mutant (C3H/HeJ) mice, indicating that TLR4 signaling pathways are directly involved in the enzyme loss. In summary, we conclude that LPS is transferred from the brain to the circulation in significant quantities in a model of CNS infection or inflammation. Subsequently, LPS that has reached the circulation stimulates a TLR4-dependent mechanism in the periphery, evoking a reduction in Cyp3a11 expression and metabolism in the liver.
lipopolysaccharide; cytochrome P-450; drug metabolism
This article has been cited by other articles:
![]() |
X. Gu, S. Ke, D. Liu, T. Sheng, P. E. Thomas, A. B. Rabson, M. A. Gallo, W. Xie, and Y. Tian Role of NF-{kappa}B in Regulation of PXR-mediated Gene Expression: A MECHANISM FOR THE SUPPRESSION OF CYTOCHROME P-450 3A4 BY PROINFLAMMATORY AGENTS J. Biol. Chem., June 30, 2006; 281(26): 17882 - 17889. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |